|Articles|January 24, 2023
Elligo Adds AI-Driven Clinical Research Study Technology
Introduces new platform which will reduce human error and accelerate trials.
Advertisement
Elligo Health Research® has introduced DataAI Connect, a new data and technology platform that will enable data-driven clinical research. DataAI Connect creates efficiencies across the clinical study workflow—reducing human error and digesting patient data to accelerate clinical trials.
Read more about the new platform
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Drug Repurposing Through AI-Driven In-Silico Clinical Trials
2
Former FDA Commissioners Warn New Vaccine Policies Could Undermine Longstanding Regulatory Framework
3
Balancing Innovation and Compliance under New GCP Guidelines
4
Obesity Trials: Scaling Operations for High-Demand Therapeutics
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
